Publicaciones en colaboración con investigadores/as de KU Leuven (13)

2023

  1. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    EJNMMI Radiopharmacy and Chemistry, Vol. 8, Núm. 1

2022

  1. Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 2, (632-651), 10.1007/s00259-021-05603-w)

    European Journal of Nuclear Medicine and Molecular Imaging

  2. EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 2, pp. 632-651

2021

  1. Highlight selection of radiochemistry and radiopharmacy developments by editorial board

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  2. Highlight selection of radiochemistry and radiopharmacy developments by editorial board (January–June 2020)

    EJNMMI Radiopharmacy and Chemistry, Vol. 6, Núm. 1

  3. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, Núm. 5, pp. 1570-1584

2020

  1. EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, Núm. 8, pp. 1885-1912

2018

  1. Automated assessment of FDG-PET for differential diagnosis in patients with neurodegenerative disorders

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 9, pp. 1557-1566

2017

  1. Position statement on radiopharmaceutical production for clinical trials

    EJNMMI Radiopharmacy and Chemistry, Vol. 2, Núm. 1

2015

  1. Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake

    Circulation, Vol. 131, Núm. 9, pp. 815-826

2014

  1. Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals

    European Journal of Nuclear Medicine and Molecular Imaging

2012

  1. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 26, pp. 10534-10539

2008

  1. Multipotent adult progenitor cells sustain function of ischemic limbs in mice

    Journal of Clinical Investigation, Vol. 118, Núm. 2, pp. 505-514